Purpose of review New discoveries focused on mitochondrial metabolism and gene silencing and their regulation by the sirtuin family of protein deacetylases is stimulating new ideas on how to improve geriatric medicine. Information about sertuins in stem cell biology is scarce. We consider recent information on sirtuin 1, its role in aging and metabolism in several species and tissues, and attempt to anticipate how it might influence stem cell aging.
Introduction
Fundamental causes of human aging, at physiological, cellular, and biochemical levels, are essentially unknown. Information obtained from studies of model organisms, such as yeast, flies, worms, and rodents as well as from rare human progeroid diseases such as Werner syndrome and Hutchinson-Gilford syndrome, have led to general hypotheses about the causes of aging. The union of several fields of biological study (mitochondrial metabolism, oxidative stress response and lifespan extension by diet) has begun to produce surprising evidence of important interrelationships of the proteins and signaling pathways in these fields and how they are involved in the aging process. These studies could ultimately lead to the development of new intervention strategies to lessen the severity of age-related illness. The present review will highlight the latest studies of the aging-related protein, sirtuin 1 (SirT1), and consider how this information may impact our understanding of stem cell aging. We focus on two areas of cellular aging, telomere erosion and oxidative damage, as they relate to the SirT1 function.
Sirtuin 1, gene silencing, and stem cell aging
The mammalian sirtuin, SirT1 (and its ortholog in other species), appears to have a key role in determining the lifespan of yeast, flies, and mice [1-3,4 ,5 ]. Mechanisms of SirT1 regulation of lifespan are being studied, but information on SirT1 in mammalian embryonic stem cells (ESCs) has, to our knowledge, been reported only by us [6 ] and one other group [7] and in adult stem cells by one group [8 ] . One mechanism by which SirT1 extends the lifespan in the budding yeast, Saccharomyces cervisiae, is by modifying the physical structure (deacetylation) of key heterochromatin regions of the genome, especially extrachomosomal rDNA circles (ERCs), which accumulate in the nucleolus [1, 9, 10] . This results in the suppression of replication of ERCs during each cell division. Budding yeasts divide by asymmetric self-renewal where daughter cells primarily receive newly synthesized organelles, whereas mother cells preferentially retain 'old' organelles [9, 10] . ERCs accumulate in mother cells in the nucleolus as the mother cell continues to divide until 500-1000 copies of ERCs are present in the nucleolus, usually after about 20 divisions. Then the nucleolus disintegrates, and mother cells no longer grow/divide and become quiescent or die. Thus, yeast mother cells have a lifespan of approximately 20 divisions.
Mutations in SirT1 cause disregulation of the promoter regions of ERCs so their numbers are prematurely increased leading to premature nucleolar decomposition and quiescence/death. Yeast cells containing an extra copy of the SirT1 gene accumulate ERCs more slowly because extra SirT1 stabilizes the chromatin structure of ERCs, suppressing their replication and accumulation allowing more divisions and longer lifespan than wild-type yeast [1, 9, 10] . Whether stem cells, which can also divide asymmetrically [11 ] , have an analogous system to define their 'division age' is unknown, but recent data from hematopoietic stem cell (HSC) transplantation studies [12] show that HSCs have 'memory' of their proliferation/differentiation state, suggested to be linked to their epigenetic programming (i.e. chromatin structure/gene silencing). This behavior is remarkably similar to yeast 'age memory'.
One hypothesis about how humans age is the 'stem cell aging' hypothesis [13 ] . It is suggested that a fundamental mechanism of aging is that as stem cells grow older, they either become quiescent or they die or both. The human body is dependent on a variety of rare stem cells which function to replace somatic cells and tissues as they get damaged, diseased, die, or otherwise lost.
Replacement of these lost cells declines progressively with age because of stem cell aging and attrition. One way in which human stem cells age is by telomere erosion. In the absence of telomerase, telomere shortening occurs and eventually causes a change in chromatin structure. This is recognized by the DNA-damage response pathway and activates programmed cell death.
In humans, telomerase activities are primarily restricted to self-renewing stem cell compartments and telomeres are shorter than in mice [14, 15] . Mice with 'humanized' telomere length and telomerase gene deletion (and other types of telomere dysfunction) readily display a premature aging/death phenotype characterized by a declining pool of self-renewing stem cells [13 ,14,15] .
The aging/death phenotype can be rescued by deleting p53, attesting to the role p53 has in the DNA-damageapoptosis pathway. However, because p53 is essential for tumor suppression, the lifespan of telomerase-deficient mice is not increased due to increased tumorigenesis. In context of a p21cip-1/waf-1-deficient background (p21cip-1/waf-1 is a downstream effector of p53), there is partial restoration of the lifespan of telomerasedeficient mice [16 ,17-19] . This is thought to be because p21cip-1/waf-1 is a potent suppressor of the cell cycle and other diverse downstream functions of p53, but is not itself a tumor suppressor.
SirT1 could have a role in telomere maintenance during stem cell aging because of its essential role in gene silencing [10] . Yeast Sir proteins are associated with telomeres [10, 20, 21] .
However, evidence from SirT1 gene-deleted ESC and SirT1 gene-deleted mice suggests that there was no widespread disruption of heterochromatin maintenance or gene silencing and no evidence of premature telomere erosion in adult splenic lymphocytes [7,22] from these animals, although telomere erosion was not measured in any adult stem cells. This conclusion was buttressed by studies in Caenorhabditis elegans [5 ], which suggested that lifespan extension of these nematodes is unrelated to gene silencing or suppression of recombination by SirT1, both features of SirT1 lifespan-extension mechanisms in yeast [1, 9, 10] . This raised the possibility that SirT1 may have no significant role in telomere maintenance in mammals. On the contrary, studies on SirT1 genedeleted mice suggest a somewhat different picture [8 ,23 ] . HSCs from SirT1 gene-deleted mice were less dependent on growth factors and had increased growth capacity, especially under stress of growth-factor deprivation compared with wild-type animals. Again, telomere erosion was not measured in these HSCs. However, the same group found that suppressing the SirT1 expression with short hairpin RNA (shRNA) in a telomerase-immortalized human fibroblast cell line enhanced their growth capacity, but neither overexpression nor suppression of SirT1 had any influence on the lifespan (Hayflick limit) in these cell lines [8 ] . Interestingly, telomerase was increased by SirT1 suppression in nonimmortalized cells. This suggests that SirT1 may be a growth factor-responsive suppressor of cell growth in certain cell types, but no correlation with stem cell aging was made. Therefore, there could still be an important link between SirT1 gene silencing and stem cell aging. SirT1 gene-deleted mice display infertility, retarded growth rate, reduced survival during adulthood, greatly reduced weight, and significantly slower rate of bone mineralization compared with wild-type mice [22] . All of these could potentially be explained by accelerated stem cell aging and attrition. The reason for male infertility was found to be due to a severe developmental defect in spermatogenesis, which is dependent on germ-line stem cells.
Telomere erosion has not been studied in stem cells from SirT1 gene-deleted mice and, therefore, effects of SirT1 loss in mice could still be linked to gene silencing or telomere destabilization, specifically in stem cells. SirT1 is abundant in mouse embryonic stem cells (mESC) [6 ,7], but mESC are not compromised in their ability to silence generalized gene expression [7] . Telomere erosion in SirT1 gene-deleted mESCs has not been studied, especially in the context of telomerase deficiency. Maintenance of telomere stability through histone deacetylation and chromatin stability modifications remains a potential mechanism by which SirT1 could influence stem cell aging and ultimately contribute to a longer lifespan.
Sirtuin 1, oxidative stress, and stem cell aging Another way SirT1 could be involved in stem cell aging is through its central role in calorie restriction-induced lifespan extension [5 , 24, 25] and its link to age-related reactive oxygen species (ROS) generation [5 , 13 ,26 ] ; both are highly dependent on mitochondrial metabolism. ROS can damage macromolecules and lipids [27] , and accumulation of these damaged molecules over time is believed to result in age-related decline in cell and tissue function. The primary source of ROS in cells is mitochondria. ROS, a by-product of ATP generation through the electron transport chain (ETC) and oxidative metabolism, is toxic and damaging at higher concentrations but is essential for proper oxygen sensing, maintenance of cellular redox state [27] [28] [29] , and regulation of proliferation and differentiation [30] [31] [32] at lower concentrations. Calorie restriction, known to extend lifespan in several model organisms including yeast, flies, worms, and rodents [5 , 24, 26 ] , appears to decrease ROS generation in several mouse tissues by forcing mitochondrial reprogramming to preferentially generate ATP by b-oxidation of fatty acids (FAs) instead of carbohydrate catabolism. Despite an increase in overall mitochondrial biogenesis caused by calorie restriction [33 ,34] , switch to b-oxidation likely results in less ROS being generated because b-oxidation bypasses electron entry into the ETC through the chain complex I [5 ], a main site of mitochondrial ROS generation when electrons get stalled down the ETC. Increased biogenesis of mitochondria during calorie restriction increases the overall number of electron entry points and likely improves electron flow, thus lessening the stalling at complex I. SirT1 has been implicated in calorie restriction-induced lifespan extension in mice because SirT1 gene-deleted mice fail to display at least some of the phenotypes of calorie restriction mice [22] , the most important of which is failure of calorie restriction to extend the lifespan in SirT1 gene-deleted mice [23 ] . Also, SirT1 transgene-overexpressing mice resemble calorie restriction mice [4 ] . Furthermore, calorie restriction upregulates SirT1 in several mouse tissues and, importantly, in human muscle tissue [33 ,35] . SirT1 deacetylates peroxisome proliferator-activated receptor gamma-coactivator-1a (PGC-1a) and increases its transcriptional activities [36, 37, 38 ] . PGC-1a transcriptionally regulates genes controlling gluconeogenesis and FA oxidation and other mitochondrial genes such as uncoupling proteins (UCPs), which are involved in the thermogenesis in neonates [24] . Calorie restriction may extend lifespan through SirT1/PGC-1a-upregulated mitochondrial biogenesis and metabolic reprogramming leading to decreased ROS generation [5 , 10,24-25,26 ,38 ] .
Effects of ROS on ESCs [6 ]
and adult stem cells [39, 40] have been studied. These studies indicate that intracellular ROS is a major contributor to cell damage, but ROS regulates proliferation, differentiation, and survival. Evidence on the influence of calorie restriction on stem cell function is scarce. Calorie restriction can ameliorate age-related decline in mouse HSC function [41, 42 ] , but ROS generation or SirT1 was not studied. This offers a clue supporting the idea that the same metabolic forces are at work in stem cells as in other cells during aging. Because mouse aging does not necessarily cause a reduction in HSC numbers, but instead causes a decline in HSC functions such as mobilization, homing, transplantation, and differentiation, HSCs appear to undergo 'cell-intrinsic aging' [43] [44] [45] [46] [47] [48] ROS damage and telomere dysfunction are implicated in age-related decline of these stem cells [13 ] . SirT1 has yet to be linked, either directly (by gene deletion studies) or indirectly (by calorie restriction or SirT1 activitymodifying drugs) to longevity of these stem cells. One report demonstrated that activation of SirT1 directly, or indirectly through an upregulation of intrinsic ROS, potently influences proliferation and cell-fate decisions in neural progenitor cells (NPCs) [50 ] . Mild ROS treatment caused a shift in NPC fate from neuronal to astroglial differentiation, mediated by SirT1, which suppresses the expression of proneuronal transcription factor, mammalian achate schute homolog 1 (MASH1). This is accomplished by specific deacetyation of histone H3K9 in the MASH1 promoter with subsequent chromatin stabilization. Mechanisms of SirT1 upregulation by mild intracellular ROS is unknown, but these findings have the potential to lay a new framework where calorie restriction, ROS, SirT1 gene silencing, mitochondrial reprogramming, and stem cell aging can be merged into a comprehensive picture of organismal aging. Mild intracellular ROS and SirT1-mediated lineage shift is particularly interesting in light of lineage shifts in aging HSCs being well documented [45] [46] [47] . It will be important to investigate effects of calorie restriction, SirT1 gene deletion, and their combination on HSC lineage choices during aging in animal models. A potential clue to these effects is that SirT1 gene-deleted mice have abnormal proportions of certain lymphocytes [22] . A similar shift (decreased lymphoid and increased myeloid cells) occurs in aged animals [45] [46] [47] . Furthermore, nuclear factorkappa B (NF-kB) is a SirT1 target [51] and is essential for differentiation of bone marrow precursor cells into osteoclasts, also regulated by ROS [52] . This might tie SirT1 to stem cell differentiation and aging because osteopenia is a hallmark of aging. Our recent report [6 ] also highlights the important distinction between mild and severe ROS damage and intrinsic and extrinsic ROS generation in mESC self-renewal. We showed that mild, endogenously generated ROS regulates apoptosis in mESCs, but this control is lost in mESCs with SirT1 gene deletion, demonstrating its requirement in this system. We also demonstrated that ROS-induced apoptosis was controlled by SirT1 through deacetylation of p53, causing p53 localization to mitochondria and initiation of Baxdependent apoptotic cascade. In contrast, when the potent exogenous oxidant, H 2 O 2 , was added to mESCs, much more apoptosis was observed in the SirT1 genedeleted cells than in wild-type cells. SirT1 was found to regulate self-renewal/proliferation and differentiation in mESC by controlling the access of p53 (by deacetylation) into the nucleus where it suppresses transcription of Nanog, which is required to maintain mESCs in an undifferentiated state. Therefore, SirT1 in mESCs maintains a balance between appropriate levels of ROS and self-renewal/proliferative capacity, findings that could have implications for studies determining conditions of specific in-vitro lineage-directed differentiation. Our findings are remarkably consistent with recent studies of HSCs from SirT1 gene-deleted mice, where SirT1 was also suggested to be a growth suppressor under growth factor withdrawal stress conditions [8 ]. Thus, SirT1 plays a role in stem cell metabolism by maintaining proper ROS levels and by limiting ROS accumulation and promoting longer stem cell life.
Finally, linkage of redox status and mild ROS to SirT1 in NPCs and mESCs is consistent with the importance of ROS signaling in human HSCs [40] . These cells have a low basal level of ROS generated by the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, NOX, which may be involved in mitochondrial bio-genesis through the activation of the PGC-1a pathway and also by serving as an oxygen sensor.
Redox status and mitochondrial ETC status in human HSC is considered important for HSC self-renewal and differentiation, analogous to that in NPCs [50 ] . There is an inverse relationship of mitochondria numbers/function per cell and surface density of HSC marker CD34 [40, 53] . The mitochondrial marker dye, rhodamine 123, which measures mitochondrial activity and membrane polarity, is used to enhance purity of self-renewing, repopulation-competent mouse HSCs, which are rhodamine 123 dim, indicating lower mitochondrial activity and membrane polarity, and is consistent with the CD34 marker relationship in human HSCs [40, 53] . There is also an age-linked relationship between mitochondrial dye efflux and the ability to repopulate the hematopoietic system of irradiated animals [53] . These studies support the notion that SirT1 might influence mitochondrial biogenesis/function in HSCs through its regulation of PGC-1a together with mild ROS and thus influence HSC aging. One study [40] proposed, on the basis of bipolar segregation of mitochondria, that this morphology might be conducive to asymmetric segregation of mitochondria during cell division. If true, this would have a striking similarity to budding yeast where newly formed organelles are primarily segregated into the budding daughter cell and the mother cell keeps the 'old' organelles [10] . This would have profound implications for HSC aging where more active mitochondria are preferentially segregated to daughter cells that are destined to initiate a differentiation program and the 'older' organelles are retained by the pluripotent (mother) HSC, allowing damage to accumulate and promote aging/ attrition. This concept could be considered based on the knowledge of asymmetry found in the HSC niche [11 ] .
Thus, SirT1 could influence stem cell aging by controlling mitochondrial biogenesis and turnover, which may be required for self-renewal.
Conclusion
We propose the following:
(1) Although the role of SirT1 in telomere maintenance remains an open question, its function in metabolically active tissues (muscle and liver) may be very similar to that in stem cells, especially SirT1's role in mitochondria and ROS generation.
(2) Genetic, hormonal, or drug manipulation of stem cell mitochondria may be useful as a research tool or to prolong longevity/stability of stem cells prior to clinical use or even to enhance their function (proliferation, engraftment, etc.), findings that may be applicable to HSC transplantation.
